Akim Felipe Santos Nobre
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Akim Felipe Santos Nobre has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Maísa Silva de Sousa
Laboratory of Molecular and Cellular Biology, Center for Tropical Medicine, Federal University of Para, Belem 66075-110, PA, Brazil
4 shared publications - Cássia Cristine Costa Pereira
Universidade federal do Pará
3 shared publications - Ingrid Christiane Silva
Universidade federal do Pará
3 shared publications - Louise de Souza Canto Covre
Universidade federal do Pará
3 shared publications - Carlos Araujo da Costa
Laboratory of Cellular and Molecular Biology, Tropical Medicine Center, Federal University of Pará (UFPA), Belém 66055-240, Brazil
2 shared publications - Danilo de Souza Almeida
Universidade federal do Pará
2 shared publications
Latest Publications
- Open Access
- 7 February 2023
- Published by MDPI AG in Preprints.org
Epidemiological Description and Molecular Characterization of Intrafamily Transmission of Human T-Lymphotropic Virus Type 1 in an Endemic Region of Brazil
Human T-lymphotropic virus type 1 (HTLV-1) is associated with neurological, degenerative, and inflammatory diseases. Brazil has regions with high prevalence rates. The prevalence among relatives of positive people is high, and intrafamily transmission causes the conservation of the infection for different generations. The investigation of epidemiological and molecular factors may clarify the factors associated with the efficacy of intrafamilial transmission of HTLV-1. Objective: To analyze the epidemiological and molecular factors associated with intrafamilial transmission of HTLV-1 in an endemic area of Brazil. Material and Methods: A cross-sectional study investigated 72 relatives from 14 families with more than one infected. Epidemiological data were collected from all family members, and genetic sequencing was performed, phylogenetic analysis of 22 positive relatives. Results: The prevalence of HTLV-1 in families with infected people was 56.94% (41/72). Twelve vertical transmission routes and ten horizontal transmission routes were identified. Phylogenetic analysis demonstrated the absence of polymorphisms between infected mother and child sequences, while sequences of couples presented nucleotide divergence of up to 3%.among themselves. It was also identified in a family with an intrafamilial transmission with the occurrence of two viral strains. Conclusion: Molecular data confirmed intrafamilial transmission. They also indicated little genetic variability between the sequenced samples of family members and those deposited in GenBank used in this study. The absence of polymorphisms was observed in cases of vertical transmission, indicating a tendency to perpetuate identical sequences regardless of the time of acquisition of the infection.
- 7 February 2023
- Published by MDPI AG in Preprints.org
Open AccessEpidemiological Description and Molecular Characterization of Intrafamily Transmission of Human T-Lymphotropic Virus Type 1 in an Endemic Region of Brazil
Human T-lymphotropic virus type 1 (HTLV-1) is associated with neurological, degenerative, and inflammatory diseases. Brazil has regions with high prevalence rates. The prevalence among relatives of positive people is high, and intrafamily transmission causes the conservation of the infection for different generations. The investigation of epidemiological and molecular factors may clarify the factors associated with the efficacy of intrafamilial transmission of HTLV-1. Objective: To analyze the epidemiological and molecular factors associated with intrafamilial transmission of HTLV-1 in an endemic area of Brazil. Material and Methods: A cross-sectional study investigated 72 relatives from 14 families with more than one infected. Epidemiological data were collected from all family members, and genetic sequencing was performed, phylogenetic analysis of 22 positive relatives. Results: The prevalence of HTLV-1 in families with infected people was 56.94% (41/72). Twelve vertical transmission routes and ten horizontal transmission routes were identified. Phylogenetic analysis demonstrated the absence of polymorphisms between infected mother and child sequences, while sequences of couples presented nucleotide divergence of up to 3%.among themselves. It was also identified in a family with an intrafamilial transmission with the occurrence of two viral strains. Conclusion: Molecular data confirmed intrafamilial transmission. They also indicated little genetic variability between the sequenced samples of family members and those deposited in GenBank used in this study. The absence of polymorphisms was observed in cases of vertical transmission, indicating a tendency to perpetuate identical sequences regardless of the time of acquisition of the infection.
- Open Access
- 24 October 2022
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 1003047
Hematological changes in human lymphotropic-T virus type 1 carriers
The human T-lymphotropic virus type 1 (HTLV-1), isolated in 1980, causes T-cell leukemia/lymphoma in adulthood, a type of lymphoproliferative disease, and chronic HTLV-1-associated myelopathy, a disease that causes paralysis of the lower limbs, which occur in about 5% of cases in this viral infection. This study aimed to establish the hematological profile of patients with HTLV-1 infection in Belém do Pará, describing the hematological parameters under study, estimating the frequency of lymphocytic atypical, and associating the hematological profile with diseases and symptoms. Hematologic data from 202 individuals were analyzed, including 87 HTLV-1 infected individuals and 115 non-HTLV-1 infected individuals as a control group, composed, at a great part, of relatives of the infected. The seroprevalence of HTLV-1 infection was observed in 71.3% of female individuals, with predominance in the group older than 50 years (44.8%). The analysis of hematological parameters showed a significant difference in the counts of the segmented cells (p = 0.0303) and eosinophils (p = 0.0092) in HTLV-1 carriers. Lymphocytic atypical was a finding present only in HTLV-1 carriers (p = 0.0001). There was no high frequency in the leukocyte counts of those infected by HTLV-1 not among them concerning a significant increase or decrease. It is concluded that HTLV-1 infection is prominent in women over 50 years old. The hematological profile of those infected shows a reduction of segmented cells, an increase of eosinophils, and the presence of atypical lymphocytes. The hematological profile of the HTLV-1 carrier should always be evaluated to identify early some diseases associated with the infection.
- 24 October 2022
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 1003047
Open AccessHematological changes in human lymphotropic-T virus type 1 carriers
The human T-lymphotropic virus type 1 (HTLV-1), isolated in 1980, causes T-cell leukemia/lymphoma in adulthood, a type of lymphoproliferative disease, and chronic HTLV-1-associated myelopathy, a disease that causes paralysis of the lower limbs, which occur in about 5% of cases in this viral infection. This study aimed to establish the hematological profile of patients with HTLV-1 infection in Belém do Pará, describing the hematological parameters under study, estimating the frequency of lymphocytic atypical, and associating the hematological profile with diseases and symptoms. Hematologic data from 202 individuals were analyzed, including 87 HTLV-1 infected individuals and 115 non-HTLV-1 infected individuals as a control group, composed, at a great part, of relatives of the infected. The seroprevalence of HTLV-1 infection was observed in 71.3% of female individuals, with predominance in the group older than 50 years (44.8%). The analysis of hematological parameters showed a significant difference in the counts of the segmented cells (p = 0.0303) and eosinophils (p = 0.0092) in HTLV-1 carriers. Lymphocytic atypical was a finding present only in HTLV-1 carriers (p = 0.0001). There was no high frequency in the leukocyte counts of those infected by HTLV-1 not among them concerning a significant increase or decrease. It is concluded that HTLV-1 infection is prominent in women over 50 years old. The hematological profile of those infected shows a reduction of segmented cells, an increase of eosinophils, and the presence of atypical lymphocytes. The hematological profile of the HTLV-1 carrier should always be evaluated to identify early some diseases associated with the infection.
- Open Access
- 1 January 2022
- Published by Editora Inovar
- p. 330-347
O VÍRUS LINFOTRÓPICO-T HUMANO DO TIPO 1 (HTLV-1) ASSOCIADO À LEUCEMIA DE CÉLULAS T ADULTAS (ATL) E À PARA PARESIA ESPÁSTICA TROPICAL (HAM/TSP)
- 1 January 2022
- Published by Editora Inovar
- p. 330-347
Open AccessO VÍRUS LINFOTRÓPICO-T HUMANO DO TIPO 1 (HTLV-1) ASSOCIADO À LEUCEMIA DE CÉLULAS T ADULTAS (ATL) E À PARA PARESIA ESPÁSTICA TROPICAL (HAM/TSP)
- Open Access
- 28 March 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (4)
Pesquisa do vírus T-linfotrópico humano (HTLV) em amostras de secreção cérvico-vaginal de mulheres, em Belém, Pará, Brasil
O Pará está entre os estados brasileiros com as mais elevadas taxas de prevalências da infecção pelo vírus T-linfotrópico humano (HTLV) nas populações onde este vírus já foi investigado. A infecção por HTLV geralmente apresenta prevalência mais elevada em mulheres com mais de 40 anos e com relacionamento estável. Além disso, as mulheres são mais susceptíveis à aquisição do vírus por via sexual do que os homens. Neste contexto, este estudo teve como objetivo detectar o genoma do provírus de HTLV em secreção cérvico-vaginal, com posterior confirmação em amostras de sangue, visando assim, propor uma nova metodologia de rastreamento desta infecção. Foram investigadas 400 mulheres de novembro de 2015 a dezembro de 2019, em Belém, Pará, Brasil. A coleta de secreção cérvico-vaginal se deu durante a realização do exame de Papanicolaou, e a de sangue periférico, durante contato posterior. O DNA das amostras foi extraído e realizada a análise molecular por Nested-PCR, seguida de digestão enzimática por Taq I, para pesquisa da infecção pelos tipos HTLV-1 e HTLV-2. Cinco (1,25%) das 400 mulheres tiveram resultado positivo para HTLV em secreção, sendo três para HTLV-1 e duas para HTLV-2. Por dificuldade de contato, só foi possível a confirmação da infecção no sangue em uma destas cinco mulheres. Nossos achados sugerem ser possível utilizar amostras de secreção cérvico-vaginal como mais uma forma de rastreamento da infecção por HTLV em mulheres.
- 28 March 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (4)
Open AccessPesquisa do vírus T-linfotrópico humano (HTLV) em amostras de secreção cérvico-vaginal de mulheres, em Belém, Pará, Brasil
O Pará está entre os estados brasileiros com as mais elevadas taxas de prevalências da infecção pelo vírus T-linfotrópico humano (HTLV) nas populações onde este vírus já foi investigado. A infecção por HTLV geralmente apresenta prevalência mais elevada em mulheres com mais de 40 anos e com relacionamento estável. Além disso, as mulheres são mais susceptíveis à aquisição do vírus por via sexual do que os homens. Neste contexto, este estudo teve como objetivo detectar o genoma do provírus de HTLV em secreção cérvico-vaginal, com posterior confirmação em amostras de sangue, visando assim, propor uma nova metodologia de rastreamento desta infecção. Foram investigadas 400 mulheres de novembro de 2015 a dezembro de 2019, em Belém, Pará, Brasil. A coleta de secreção cérvico-vaginal se deu durante a realização do exame de Papanicolaou, e a de sangue periférico, durante contato posterior. O DNA das amostras foi extraído e realizada a análise molecular por Nested-PCR, seguida de digestão enzimática por Taq I, para pesquisa da infecção pelos tipos HTLV-1 e HTLV-2. Cinco (1,25%) das 400 mulheres tiveram resultado positivo para HTLV em secreção, sendo três para HTLV-1 e duas para HTLV-2. Por dificuldade de contato, só foi possível a confirmação da infecção no sangue em uma destas cinco mulheres. Nossos achados sugerem ser possível utilizar amostras de secreção cérvico-vaginal como mais uma forma de rastreamento da infecção por HTLV em mulheres.
- Open Access
- 2 March 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (3)
Análise dos níveis de carga proviral em portadores de HTLV-1 com diferentes condições de comprometimento neurológico
Objetivos: Analisar os níveis da carga proviral (CPV) em portadores de HTLV-1 com diferentes condições de comprometimento neurológico. Metodologia: Estudo transversal, realizado de março a outubro de 2017, com 43 pacientes com HTLV-1, divididos em três grupos por ordem decrescente de envolvimento neurológico, segundo proposta atualizada dos critérios de diagnóstico clínico para HAM/TSP: Definidos para HAM/TSP (Grupo 1, n=7); Prováveis/Possíveis para HAM/TSP (Grupo 2, n=9); Sem HAM/TSP (Grupo 3, n=27). O teste ANOVA (um critério) foi utilizado para verificar a diferença entre as médias de CPV dos grupos (p-valor≤0,05). Resultados: Os grupos apresentaram os seguintes valores médios de CPV: G1=9.00±11.18; G2=1.88±3.92; G3=2.81±4.03 cópias/106 PBMC. Na comparação intergrupo, da diferença entre as médias de CPV, foi observada diferença significativa entre os grupos 1 e 2 e entre os grupos 1 e 3 (p
- 2 March 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (3)
Open AccessAnálise dos níveis de carga proviral em portadores de HTLV-1 com diferentes condições de comprometimento neurológico
Objetivos: Analisar os níveis da carga proviral (CPV) em portadores de HTLV-1 com diferentes condições de comprometimento neurológico. Metodologia: Estudo transversal, realizado de março a outubro de 2017, com 43 pacientes com HTLV-1, divididos em três grupos por ordem decrescente de envolvimento neurológico, segundo proposta atualizada dos critérios de diagnóstico clínico para HAM/TSP: Definidos para HAM/TSP (Grupo 1, n=7); Prováveis/Possíveis para HAM/TSP (Grupo 2, n=9); Sem HAM/TSP (Grupo 3, n=27). O teste ANOVA (um critério) foi utilizado para verificar a diferença entre as médias de CPV dos grupos (p-valor≤0,05). Resultados: Os grupos apresentaram os seguintes valores médios de CPV: G1=9.00±11.18; G2=1.88±3.92; G3=2.81±4.03 cópias/106 PBMC. Na comparação intergrupo, da diferença entre as médias de CPV, foi observada diferença significativa entre os grupos 1 e 2 e entre os grupos 1 e 3 (p
- Open Access
- 1 February 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (2)
Prevalência de Strongyloides stercoralis em portadores do Vírus Linfotrópico-T Humano (HTLV) atendidos no Núcleo de Medicina Tropical da Universidade Federal do Pará
Este estudo tem como objetivo descrever o perfil epidemiológico dos pacientes coinfectados por HTLV-1 e Strongyloides stercoralis, oriundos do Núcleo de Medicina Tropical (NMT) localizado na Universidade Federal do Pará (UFPA). Foi realizada uma análise quantitativa, retrospectiva e transversal, na qual foram utilizadas informações de pacientes com sorologia positiva para HTLV, confirmada pela Reação em Cadeia da Polimerase (PCR) para HTLV-1 ou HTLV-2, além de exames parasitológicos confirmados pelo método de Hoffman. Dos 4.679 pacientes examinados foram detectadas 538 amostras positivas, sendo 432 para HTLV-1 (80%) e 106 para HTLV-2 (20%). No exame parasitológico foram obtidas 14 amostras positivas para o S. stercoralis e 81 negativas de um total de 95 pacientes que levaram seu material para a análise, onde foi possível determinar uma prevalência de coinfecção de 14,7% entre os dois agentes infecciosos. Observou-se um predomínio de pacientes positivos para HTLV-1 do sexo feminino em relação ao masculino. Isso pode ocorrer devido à facilidade da transmissão através da relação sexual e também pelos efeitos hormonais das mulheres, deixando-as mais suscetíveis à infeção. A partir disso, verificou-se que pacientes com HTLV-1/2 podem também apresentar coinfecção com S. Stercoralis, sobretudo no estado do Pará.
- 1 February 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (2)
Open AccessPrevalência de Strongyloides stercoralis em portadores do Vírus Linfotrópico-T Humano (HTLV) atendidos no Núcleo de Medicina Tropical da Universidade Federal do Pará
Este estudo tem como objetivo descrever o perfil epidemiológico dos pacientes coinfectados por HTLV-1 e Strongyloides stercoralis, oriundos do Núcleo de Medicina Tropical (NMT) localizado na Universidade Federal do Pará (UFPA). Foi realizada uma análise quantitativa, retrospectiva e transversal, na qual foram utilizadas informações de pacientes com sorologia positiva para HTLV, confirmada pela Reação em Cadeia da Polimerase (PCR) para HTLV-1 ou HTLV-2, além de exames parasitológicos confirmados pelo método de Hoffman. Dos 4.679 pacientes examinados foram detectadas 538 amostras positivas, sendo 432 para HTLV-1 (80%) e 106 para HTLV-2 (20%). No exame parasitológico foram obtidas 14 amostras positivas para o S. stercoralis e 81 negativas de um total de 95 pacientes que levaram seu material para a análise, onde foi possível determinar uma prevalência de coinfecção de 14,7% entre os dois agentes infecciosos. Observou-se um predomínio de pacientes positivos para HTLV-1 do sexo feminino em relação ao masculino. Isso pode ocorrer devido à facilidade da transmissão através da relação sexual e também pelos efeitos hormonais das mulheres, deixando-as mais suscetíveis à infeção. A partir disso, verificou-se que pacientes com HTLV-1/2 podem também apresentar coinfecção com S. Stercoralis, sobretudo no estado do Pará.
- Open Access
- 2 May 2018
- Published by Springer Nature in Virology Journal
- Vol. 15 (1) , 80
Stability of the HTLV-1 glycoprotein 46 (gp46) gene in an endemic region of the Brazilian Amazon and the presence of a significant mutation (N93D) in symptomatic patients
The human T-lymphotropic virus type 1 (HTLV-1) affects 2–5 million people worldwide, and is associated with a number of degenerative and infectious diseases. The Envelope glycoproteins (gp) are highly conserved among the different HTLV-1 isolates, although nucleotide substitutions in the region that codifies these proteins may influence both the infectivity and the replication of the virus. The gp46 gene has functional domains which have been associated with the inhibition of the formation of the syncytium, cell-cell transmission, and the production of antibodies. The present study investigated the genetic stability of the gp46 gene of HTLV-1 in an endemic region of Brazilian Amazonia. Index case (IC - a sample of a given family group) carriers of HTLV-1 were investigated in the metropolitan region of Belém (Pará, Brazil) between January 2010 (registered retrospectively) and December 2015. The sequences that codify the gp46 were amplified by PCR, purified and sequenced (MF084788–MF084825). The gene was characterized using bioinformatics and Bayesian Inference. The 40 patients analyzed had a mean age of 45.2 years and 70% presented some type of symptom, with a predominance of pain and sensitivity, dysautonomia, and motor disorders. All patients presented the aA (Transcontinental Cosmopolitan) genotype, with an extremely low mutation rate, which is characteristic of the codifying region (aA – 1.83 × 10–4 mutations per site per year). The gp46 gene had a nucleotide diversity of between 0.00% and 2.0%. Amino acid mutations were present in 66.6% of the samples of individuals with signs/symptoms or diseases associated with HTLV-1 (p = 0.0091). Of the three most frequent mutations, the previously undescribed N93D mutant was invariably associated with symptomatic cases. The aA HTLV-1 subtype is predominant in the metropolitan region of Belém and presented a high degree of genetic stability in the codifying region. The rare N93D amino acid mutation may be associated with the clinical manifestations of this viral infection. Little is known of the phylogeny of HTLV-1 in the endemic region of Brazilian Amazonia, and few complete gene sequences are available for the gp46 glycoprotein from the local population. The nucleotide sequences of the viral gp46 gene recorded in the present study confirmed the genetic stability of the region, and pointed to a homogeneous viral group, with local geographic characteristics. Further research will be necessary to more fully understand the molecular diversity of this protein, given the potential of this codifying region as a model for an effective HTLV-1 vaccine. The identification of a rare mutation (N93D), present only in symptomatic patients, should also be investigated further as a potential clinical marker. ISRCTN 12345678, registered 28 September 2014.
- 2 May 2018
- Published by Springer Nature in Virology Journal
- Vol. 15 (1) , 80
Open AccessStability of the HTLV-1 glycoprotein 46 (gp46) gene in an endemic region of the Brazilian Amazon and the presence of a significant mutation (N93D) in symptomatic patients
The human T-lymphotropic virus type 1 (HTLV-1) affects 2–5 million people worldwide, and is associated with a number of degenerative and infectious diseases. The Envelope glycoproteins (gp) are highly conserved among the different HTLV-1 isolates, although nucleotide substitutions in the region that codifies these proteins may influence both the infectivity and the replication of the virus. The gp46 gene has functional domains which have been associated with the inhibition of the formation of the syncytium, cell-cell transmission, and the production of antibodies. The present study investigated the genetic stability of the gp46 gene of HTLV-1 in an endemic region of Brazilian Amazonia. Index case (IC - a sample of a given family group) carriers of HTLV-1 were investigated in the metropolitan region of Belém (Pará, Brazil) between January 2010 (registered retrospectively) and December 2015. The sequences that codify the gp46 were amplified by PCR, purified and sequenced (MF084788–MF084825). The gene was characterized using bioinformatics and Bayesian Inference. The 40 patients analyzed had a mean age of 45.2 years and 70% presented some type of symptom, with a predominance of pain and sensitivity, dysautonomia, and motor disorders. All patients presented the aA (Transcontinental Cosmopolitan) genotype, with an extremely low mutation rate, which is characteristic of the codifying region (aA – 1.83 × 10–4 mutations per site per year). The gp46 gene had a nucleotide diversity of between 0.00% and 2.0%. Amino acid mutations were present in 66.6% of the samples of individuals with signs/symptoms or diseases associated with HTLV-1 (p = 0.0091). Of the three most frequent mutations, the previously undescribed N93D mutant was invariably associated with symptomatic cases. The aA HTLV-1 subtype is predominant in the metropolitan region of Belém and presented a high degree of genetic stability in the codifying region. The rare N93D amino acid mutation may be associated with the clinical manifestations of this viral infection. Little is known of the phylogeny of HTLV-1 in the endemic region of Brazilian Amazonia, and few complete gene sequences are available for the gp46 glycoprotein from the local population. The nucleotide sequences of the viral gp46 gene recorded in the present study confirmed the genetic stability of the region, and pointed to a homogeneous viral group, with local geographic characteristics. Further research will be necessary to more fully understand the molecular diversity of this protein, given the potential of this codifying region as a model for an effective HTLV-1 vaccine. The identification of a rare mutation (N93D), present only in symptomatic patients, should also be investigated further as a potential clinical marker. ISRCTN 12345678, registered 28 September 2014.
- Open Access
- 20 March 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (3) , e0194184
Low genetic diversity of the Human T-cell Lymphotropic Virus (HTLV-1) in an endemic area of the Brazilian Amazon basin
The Human T-cell Lymphotropic Virus (HTLV-1) is a Deltaretrovírus that was first isolated in the 1970s, and associated with Adult T-cell Leucemia-Lymphoma (ATLL), and subsequently to Tropical Spastic Paraparesis-Myelopathy (TSP/HAM). The genetic diversity of the virus varies among geographic regions, although its mutation rate is very low (approximately 1% per thousand years) in comparison with other viruses. The present study determined the genetic diversity of HTLV-1 in the metropolitan region of Belém, in northern Brazil. Blood samples were obtained from patients at the UFPA Tropical Medicine Nucleus between January 2010 and December 2013. The DNA was extracted and the PX region of the HTLV was amplified using nested PCR. The positive samples were then digested using the Taq1 enzyme for the identification and differentiation of the HTLV-1 and HTLV-2. The 5’LTR region of the positive HTLV-1 samples were amplified by nested PCR, and then sequenced genetically. The phylogenetic analysis of the samples was based on the maximum likelihood method and the evolutionary profile was analyzed by the Bayesian approach. Overall, 78 samples tested positive for HTLV-1, and 44 were analyzed here. The aA (cosmopolitan-transcontinental) subtype was recorded in all the samples. The following evolutionary rates were recorded for the different subtypes–a: 2.10−3, b: 2.69. 10−2, c: 6.23. 10−2, d: 3.08. 10−2, e: 6. 10−2, f: 1.78. 10−3, g: 2.2. 10−2 mutations per site per year. The positive HTLV-1 samples tested in the present study were characterized by their low genetic diversity and high degree of stability.
- 20 March 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (3) , e0194184
Open AccessLow genetic diversity of the Human T-cell Lymphotropic Virus (HTLV-1) in an endemic area of the Brazilian Amazon basin
The Human T-cell Lymphotropic Virus (HTLV-1) is a Deltaretrovírus that was first isolated in the 1970s, and associated with Adult T-cell Leucemia-Lymphoma (ATLL), and subsequently to Tropical Spastic Paraparesis-Myelopathy (TSP/HAM). The genetic diversity of the virus varies among geographic regions, although its mutation rate is very low (approximately 1% per thousand years) in comparison with other viruses. The present study determined the genetic diversity of HTLV-1 in the metropolitan region of Belém, in northern Brazil. Blood samples were obtained from patients at the UFPA Tropical Medicine Nucleus between January 2010 and December 2013. The DNA was extracted and the PX region of the HTLV was amplified using nested PCR. The positive samples were then digested using the Taq1 enzyme for the identification and differentiation of the HTLV-1 and HTLV-2. The 5’LTR region of the positive HTLV-1 samples were amplified by nested PCR, and then sequenced genetically. The phylogenetic analysis of the samples was based on the maximum likelihood method and the evolutionary profile was analyzed by the Bayesian approach. Overall, 78 samples tested positive for HTLV-1, and 44 were analyzed here. The aA (cosmopolitan-transcontinental) subtype was recorded in all the samples. The following evolutionary rates were recorded for the different subtypes–a: 2.10−3, b: 2.69. 10−2, c: 6.23. 10−2, d: 3.08. 10−2, e: 6. 10−2, f: 1.78. 10−3, g: 2.2. 10−2 mutations per site per year. The positive HTLV-1 samples tested in the present study were characterized by their low genetic diversity and high degree of stability.
- 1 June 2014
- Published by Instituto Evandro Chagas in Revista Pan-Amazônica de Saúde
- Vol. 5 (2) , 37-41
Primeira detecção de coronavírus humano associado à infecção respiratória aguda na Região Norte do Brasil
- 1 June 2014
- Published by Instituto Evandro Chagas in Revista Pan-Amazônica de Saúde
- Vol. 5 (2) , 37-41
Primeira detecção de coronavírus humano associado à infecção respiratória aguda na Região Norte do Brasil